Effects of PIOMI on Oral Feeding of the Premature Infants
NCT ID: NCT04290338
Last Updated: 2020-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2020-03-31
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PIOMI Group
Patients in this group will receive the intraoral and extraoral stimulations provided by the PIOMI protocol. These stimulations will last 5 minutes and will be performed once a day for 7 consecutive days for each patient.
PIOMI
Intraoral and extraoral stimulation.
Control Group
Patients in this group will receive classic care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PIOMI
Intraoral and extraoral stimulation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical stability;
* possible presence of nasogastric or oro-gastric tube;
* non-invasive respiratory support (oxygen, high flows)
Exclusion Criteria
* absence of clinical stability
* invasive respiratory support (CPAP)
* previous surgical interventions
* ongoing infections
* congenital and / or chromosomal diseases
* brain, metabolic, cardiac, gastrointestinal diseases
* presence of bronchopulmonary dysplasia
25 Weeks
33 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Odoardo Picciolini
Role: STUDY_DIRECTOR
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PIOMI2020Policlinico
Identifier Type: -
Identifier Source: org_study_id